ProAssurance Co. (NYSE:PRA – Free Report) – Analysts at Zacks Research boosted their Q1 2025 earnings estimates for ProAssurance in a report issued on Thursday, December 5th. Zacks Research analyst K. Dey now expects that the insurance provider will earn $0.18 per share for the quarter, up from their prior forecast of $0.17. The consensus estimate for ProAssurance’s current full-year earnings is $0.80 per share. Zacks Research also issued estimates for ProAssurance’s Q2 2025 earnings at $0.20 EPS, Q3 2025 earnings at $0.23 EPS, FY2025 earnings at $0.84 EPS, Q1 2026 earnings at $0.21 EPS, Q2 2026 earnings at $0.22 EPS, Q3 2026 earnings at $0.24 EPS and FY2026 earnings at $0.94 EPS.
PRA has been the subject of a number of other reports. StockNews.com raised shares of ProAssurance from a “hold” rating to a “buy” rating in a report on Tuesday. Truist Financial upped their target price on shares of ProAssurance from $14.00 to $18.00 and gave the company a “hold” rating in a report on Tuesday, November 12th. Finally, Piper Sandler cut shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 target price for the company. in a report on Monday, November 11th.
ProAssurance Stock Down 1.1 %
Shares of PRA stock opened at $16.65 on Monday. ProAssurance has a 12 month low of $10.76 and a 12 month high of $17.79. The stock has a market cap of $851.75 million, a P/E ratio of 20.06 and a beta of 0.27. The company has a current ratio of 0.28, a quick ratio of 0.28 and a debt-to-equity ratio of 0.35. The company has a 50 day simple moving average of $15.88 and a two-hundred day simple moving average of $13.97.
Hedge Funds Weigh In On ProAssurance
Institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP lifted its position in ProAssurance by 3.0% during the third quarter. Wellington Management Group LLP now owns 3,164,085 shares of the insurance provider’s stock valued at $47,588,000 after purchasing an additional 91,987 shares during the last quarter. State Street Corp grew its position in shares of ProAssurance by 1.8% in the 3rd quarter. State Street Corp now owns 1,968,754 shares of the insurance provider’s stock worth $29,610,000 after buying an additional 34,247 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in shares of ProAssurance by 1.4% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 1,311,435 shares of the insurance provider’s stock worth $19,724,000 after buying an additional 18,718 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in ProAssurance by 0.3% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 587,901 shares of the insurance provider’s stock worth $8,842,000 after purchasing an additional 1,738 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its stake in ProAssurance by 91.4% in the 3rd quarter. Assenagon Asset Management S.A. now owns 485,501 shares of the insurance provider’s stock worth $7,302,000 after purchasing an additional 231,852 shares in the last quarter. 85.58% of the stock is owned by hedge funds and other institutional investors.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
See Also
- Five stocks we like better than ProAssurance
- Best Stocks Under $10.00
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- How to Effectively Use the MarketBeat Ratings Screener
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.